| Douglas J. Herrington |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-0.19% |
$204,250 |
$204.25 |
-1,000 |
521,361 |
02 Mar 2026 |
Direct |
| Senior David Zapolsky |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-20.5% |
$2,187,624 |
$205.43 |
-10,649 |
41,190 |
24 Feb 2026 |
Direct |
| Andrew R. Jassy |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-0.88% |
$4,077,378 |
$205.18 |
-19,872 |
2,238,118 |
23 Feb 2026 |
Direct |
| Matthew S. Garman |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-65.4% |
$3,642,842 |
$205.22 |
-17,751 |
9,405 |
23 Feb 2026 |
Direct |
| Senior David Zapolsky |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-12% |
$1,457,990 |
$205.35 |
-7,100 |
51,839 |
23 Feb 2026 |
Direct |
| Douglas J. Herrington |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-1.29% |
$1,406,785 |
$205.82 |
-6,835 |
522,361 |
23 Feb 2026 |
Direct |
| Shelley Reynolds |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-2.2% |
$554,892 |
$205.90 |
-2,695 |
119,780 |
23 Feb 2026 |
Direct |
| Andrew R. Jassy |
AMZN |
Common Stock, par value $.01 per share |
Options Exercise |
2.25% |
|
|
49,680 |
2,257,990 |
21 Feb 2026 |
Direct |
| Andrew R. Jassy |
AMZN |
Restricted Stock Unit Award |
Options Exercise |
-100% |
|
|
-49,680 |
0 |
21 Feb 2026 |
Direct |
| Matthew S. Garman |
AMZN |
Common Stock, par value $.01 per share |
Options Exercise |
332.9% |
|
|
20,883 |
27,156 |
21 Feb 2026 |
Direct |
| Matthew S. Garman |
AMZN |
Restricted Stock Unit Award |
Options Exercise |
-51.8% |
|
|
-20,883 |
19,440 |
21 Feb 2026 |
Direct |
| Senior David Zapolsky |
AMZN |
Common Stock, par value $.01 per share |
Options Exercise |
43.1% |
|
|
17,749 |
58,939 |
21 Feb 2026 |
Direct |
| Senior David Zapolsky |
AMZN |
Restricted Stock Unit Award |
Options Exercise |
-100% |
|
|
-17,749 |
0 |
21 Feb 2026 |
Direct |
| Senior Brian T. Olsavsky |
AMZN |
Common Stock, par value $.01 per share |
Options Exercise |
26.6% |
|
|
17,749 |
84,499 |
21 Feb 2026 |
Direct |
| Senior Brian T. Olsavsky |
AMZN |
Restricted Stock Unit Award |
Options Exercise |
-100% |
|
|
-17,749 |
0 |
21 Feb 2026 |
Direct |
| Douglas J. Herrington |
AMZN |
Common Stock, par value $.01 per share |
Options Exercise |
3.34% |
|
|
17,087 |
529,196 |
21 Feb 2026 |
Direct |
| Douglas J. Herrington |
AMZN |
Restricted Stock Unit Award |
Options Exercise |
-100% |
|
|
-17,087 |
0 |
21 Feb 2026 |
Direct |
| Shelley Reynolds |
AMZN |
Common Stock, par value $.01 per share |
Options Exercise |
2.25% |
|
|
2,695 |
122,475 |
21 Feb 2026 |
Direct |
| Shelley Reynolds |
AMZN |
Restricted Stock Unit Award |
Options Exercise |
-100% |
|
|
-2,695 |
0 |
21 Feb 2026 |
Direct |
| Douglas J. Herrington |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-0.93% |
$948,990 |
$198.37 |
-4,784 |
512,109 |
17 Feb 2026 |
Direct |
| Douglas J. Herrington |
AMZN |
Common Stock, par value $.01 per share |
Options Exercise |
2.37% |
|
|
11,959 |
516,893 |
15 Feb 2026 |
Direct |
| Douglas J. Herrington |
AMZN |
Restricted Stock Unit Award |
Options Exercise |
-15.3% |
|
|
-11,959 |
66,280 |
15 Feb 2026 |
Direct |
| Jamie S. Gorelick |
AMZN |
Common Stock, par value $.01 per share |
Options Exercise |
7.02% |
|
|
2,677 |
40,794 |
15 Feb 2026 |
Direct |
| Jamie S. Gorelick |
AMZN |
Restricted Stock Unit Award |
Options Exercise |
-50% |
|
|
-2,677 |
2,677 |
15 Feb 2026 |
Direct |
| Wendell P. Weeks |
AMZN |
Common Stock, par value $.01 per share |
Options Exercise |
4.09% |
|
|
1,816 |
46,216 |
15 Feb 2026 |
Direct |
| Wendell P. Weeks |
AMZN |
Restricted Stock Unit Award |
Options Exercise |
-33.3% |
|
|
-1,816 |
3,632 |
15 Feb 2026 |
Direct |
| Keith B. Alexander |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-12.6% |
$183,492 |
$203.88 |
-900 |
6,270 |
12 Feb 2026 |
Direct |
| Douglas J. Herrington |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-0.2% |
$208,000 |
$208.00 |
-1,000 |
504,934 |
11 Feb 2026 |
Direct |
| Douglas J. Herrington |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-0.49% |
$583,050 |
$233.22 |
-2,500 |
505,934 |
01 Dec 2025 |
Direct |
| Senior David Zapolsky |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-24.8% |
$3,019,189 |
$222.49 |
-13,570 |
41,190 |
24 Nov 2025 |
Direct |
| Andrew R. Jassy |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-0.89% |
$4,310,952 |
$216.94 |
-19,872 |
2,208,310 |
21 Nov 2025 |
Direct |
| Andrew R. Jassy |
AMZN |
Common Stock, par value $.01 per share |
Options Exercise |
2.28% |
|
|
49,680 |
2,228,182 |
21 Nov 2025 |
Direct |
| Andrew R. Jassy |
AMZN |
Restricted Stock Unit Award |
Options Exercise |
-66.8% |
|
|
-49,680 |
24,680 |
21 Nov 2025 |
Direct |
| Matthew S. Garman |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-73.9% |
$3,853,946 |
$216.90 |
-17,768 |
6,273 |
21 Nov 2025 |
Direct |
| Matthew S. Garman |
AMZN |
Common Stock, par value $.01 per share |
Options Exercise |
666.1% |
|
|
20,903 |
24,041 |
21 Nov 2025 |
Direct |
| Matthew S. Garman |
AMZN |
Restricted Stock Unit Award |
Options Exercise |
-44.8% |
|
|
-20,903 |
25,740 |
21 Nov 2025 |
Direct |
| Senior David Zapolsky |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-11.5% |
$1,540,277 |
$216.94 |
-7,100 |
54,760 |
21 Nov 2025 |
Direct |
| Senior David Zapolsky |
AMZN |
Common Stock, par value $.01 per share |
Options Exercise |
40.2% |
|
|
17,750 |
61,860 |
21 Nov 2025 |
Direct |
| Senior David Zapolsky |
AMZN |
Restricted Stock Unit Award |
Options Exercise |
-66.9% |
|
|
-17,750 |
8,780 |
21 Nov 2025 |
Direct |
| Senior Brian T. Olsavsky |
AMZN |
Common Stock, par value $.01 per share |
Options Exercise |
36.2% |
|
|
17,750 |
66,750 |
21 Nov 2025 |
Direct |
| Senior Brian T. Olsavsky |
AMZN |
Restricted Stock Unit Award |
Options Exercise |
-66.9% |
|
|
-17,750 |
8,780 |
21 Nov 2025 |
Direct |
| Douglas J. Herrington |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-1.33% |
$1,479,098 |
$216.40 |
-6,835 |
508,434 |
21 Nov 2025 |
Direct |
| Douglas J. Herrington |
AMZN |
Common Stock, par value $.01 per share |
Options Exercise |
3.43% |
|
|
17,087 |
515,269 |
21 Nov 2025 |
Direct |
| Douglas J. Herrington |
AMZN |
Restricted Stock Unit Award |
Options Exercise |
-63.6% |
|
|
-17,087 |
9,760 |
21 Nov 2025 |
Direct |
| Shelley Reynolds |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-2.2% |
$583,222 |
$216.41 |
-2,695 |
119,780 |
21 Nov 2025 |
Direct |
| Shelley Reynolds |
AMZN |
Common Stock, par value $.01 per share |
Options Exercise |
2.25% |
|
|
2,695 |
122,475 |
21 Nov 2025 |
Direct |
| Shelley Reynolds |
AMZN |
Restricted Stock Unit Award |
Options Exercise |
-60% |
|
|
-2,695 |
1,800 |
21 Nov 2025 |
Direct |
| Daniel P. Huttenlocher |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-4.52% |
$280,317 |
$226.61 |
-1,237 |
26,148 |
20 Nov 2025 |
Direct |
| Douglas J. Herrington |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-0.95% |
$1,113,263 |
$232.71 |
-4,784 |
498,182 |
17 Nov 2025 |
Direct |
| Keith B. Alexander |
AMZN |
Common Stock, par value $.01 per share |
Sale |
-11.2% |
$209,700 |
$233.00 |
-900 |
7,170 |
17 Nov 2025 |
Direct |